
|Videos|April 2, 2016
How Pharmacists Can Improve Adherence to Novel Oral Anticoagulants
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses some ways pharmacists can improve patient adherence to novel oral anticoagulants.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses some ways pharmacists can improve patient adherence to novel oral anticoagulants.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5














































































































































































































